Annual Short Term Debt
$15.85 M
+$7.73 M+95.21%
December 31, 2022
Summary
- As of February 10, 2025, ORTX annual short term debt is $15.85 million, with the most recent change of +$7.73 million (+95.21%) on December 31, 2022.
- During the last 3 years, ORTX annual short term debt has risen by +$9.96 million (+169.06%).
Performance
ORTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Short Term Debt
$14.98 M
-$1.05 M-6.56%
September 30, 2023
Summary
- As of February 10, 2025, ORTX quarterly short term debt is $14.98 million, with the most recent change of -$1.05 million (-6.56%) on September 30, 2023.
- Over the past year, ORTX quarterly short term debt has increased by +$872.00 thousand (+6.18%).
Performance
ORTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
ORTX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +95.2% | +6.2% |
| 3 y3 years | +169.1% | +27.3% |
| 5 y5 years | - | - |
ORTX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -48.8% | -6.6% | -45.8% |
| 5 y | 5-year | at high | -62.8% | -6.6% | -60.7% |
| alltime | all time | at high | -100.0% | -6.6% | -100.0% |
Orchard Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $14.98 M(-6.6%) |
| Jun 2023 | - | $16.03 M(+0.8%) |
| Mar 2023 | - | $15.90 M(+0.3%) |
| Dec 2022 | $15.85 M(+95.2%) | $15.85 M(+12.4%) |
| Sep 2022 | - | $14.11 M(+15.9%) |
| Jun 2022 | - | $12.17 M(+19.5%) |
| Mar 2022 | - | $10.19 M(+25.4%) |
| Dec 2021 | $8.12 M | $8.12 M(-1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $8.26 M(+0.1%) |
| Jun 2021 | - | $8.24 M(-44.7%) |
| Mar 2021 | - | $14.91 M(+8.1%) |
| Dec 2020 | $13.79 M(+134.1%) | $13.79 M(+17.2%) |
| Sep 2020 | - | $11.77 M(+77.8%) |
| Jun 2020 | - | $6.62 M(+6.7%) |
| Mar 2020 | - | $6.20 M(+5.3%) |
| Dec 2019 | $5.89 M(>+9900.0%) | $5.89 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Orchard Therapeutics annual short term debt?
- What is the all time high annual short term debt for Orchard Therapeutics?
- What is Orchard Therapeutics annual short term debt year-on-year change?
- What is Orchard Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Orchard Therapeutics?
- What is Orchard Therapeutics quarterly short term debt year-on-year change?
What is Orchard Therapeutics annual short term debt?
The current annual short term debt of ORTX is $15.85 M
What is the all time high annual short term debt for Orchard Therapeutics?
Orchard Therapeutics all-time high annual short term debt is $15.85 M
What is Orchard Therapeutics annual short term debt year-on-year change?
Over the past year, ORTX annual short term debt has changed by +$7.73 M (+95.21%)
What is Orchard Therapeutics quarterly short term debt?
The current quarterly short term debt of ORTX is $14.98 M
What is the all time high quarterly short term debt for Orchard Therapeutics?
Orchard Therapeutics all-time high quarterly short term debt is $16.03 M
What is Orchard Therapeutics quarterly short term debt year-on-year change?
Over the past year, ORTX quarterly short term debt has changed by +$872.00 K (+6.18%)